Could a simple ear device ease chemo nausea without extra drugs?

NCT ID NCT04937309

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a non-invasive device that gently stimulates a nerve in the ear can help prevent nausea caused by chemotherapy in breast cancer patients. Participants use the device twice daily around their chemo sessions, alongside standard anti-nausea medication. The goal is to see if adding this stimulation reduces nausea more than standard care alone or a sham device.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
non-invasive auricular vagal stimulation device
What this could lead to
If effective, this device could offer a drug-free way to reduce nausea during chemotherapy, improving quality of life for breast cancer patients.
What could go wrong
This is a mid-sized trial testing a device that may not outperform a sham (fake) device. Nausea is subjective, and results may not apply to other cancers or chemotherapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH BLOIS

    ACTIVE_NOT_RECRUITING

    Blois, France

  • CHRU Bretonneau

    RECRUITING

    Tours, France

  • CORT37

    RECRUITING

    Chambray-lès-Tours, France

  • Ch Chateauroux

    RECRUITING

    Châteauroux, France

  • Ch Chinon

    RECRUITING

    Saint-Benoît-la-Forêt, France

  • Ch Orleans

    ACTIVE_NOT_RECRUITING

    Orléans, France

  • Chru Morvan

    RECRUITING

    Brest, France

  • Clinique Victor Hugo

    RECRUITING

    Le Mans, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.